Aastrom Biosciences (ASTM), More Dilution on the Horizon
February 4th, 2011
No comments
New proxy to increase number of authorized shares to raise additional capital or acquire another company Read more…
Categories: NASDAQ: ASTM, New Proxy, Stem Cell Research, Stem Cell Technology
